Preclinical Metrics Correlate With Drug Activity in Phase II Trials of Targeted Therapies for Non-Small Cell Lung Cancer
Rybinski, Brad, Hosgood, H. Dean, Wiener, Sara L., Weiser, Daniel A.Volume:
10
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2020.587377
Date:
November, 2020
File:
PDF, 643 KB
2020